Skip to main content
. 2020 Oct 2;28:102456. doi: 10.1016/j.nicl.2020.102456

Fig. 3.

Fig. 3

The prevalence of pcT2wFLAIR CSF enhancement across disease groups. Point estimates are represented by squares for individual studies, and diamonds for summed disease categories. The area of each point estimate is proportional to the size of each study. The error bars represent 95% confidence intervals. N = sample size, n = number of cases with pcT2wFLAIR CSF enhancement. * Study sample included both cases with ischemic stroke as well as cases with intracerebral hemorrhage.